Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated Markets
Author:
Funder
Sandoz
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Link
http://link.springer.com/content/pdf/10.1007/s40259-016-0169-2.pdf
Reference43 articles.
1. Metcalf D. The granulocyte-macrophage colony stimulating factors. Cell. 1985;43(1):5–6.
2. Nemunaitis J. A comparative review of colony-stimulating factors. Drugs. 1997;54(5):709–29.
3. Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011;47(1):8–32.
4. Ye SG, Ding YI, Li L, et al. Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia. Mol Clin Oncol. 2015;3(3):730–6.
5. Gascon P, Tesch H, Verpoort K, et al. Clinical experience with Zarzio® in Europe: what have we learned? Support Care Cancer. 2013;21(10):2925–32.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effective Amino Acid Sequencing of Intact Filgrastim by Multimodal Mass Spectrometry with Topdownr;Journal of the American Society for Mass Spectrometry;2022-10-20
2. Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review;European Journal of Pharmaceutical Sciences;2020-11
3. Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs;Journal of Chemistry;2019-02-27
4. Analytical Comparison of the Originator Granulocyte-colony Stimulating Factor Filgrastim and its Biosimilars;Current Pharmaceutical Design;2018-12-08
5. Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review;BioDrugs;2018-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3